Molecular Diagnostics
Low-Cost Multiplexed Electrochemical Biomarker Detection Platform to Be Commercialized in POC Diagnostics
A low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of patients and primary health practitioners. More...09 Mar 2022
Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases
Roughly one in every three children with a type of kidney cancer known as Wilms tumor, or nephroblastoma, carry germline alterations implicated in hereditary cancer risk, new research suggests — findings that have prompted more widespread genetic testing for Dutch children with the condition. More...08 Mar 2022
Liquid Biopsy of Cerebrospinal Fluid for Diagnosis of Medulloblastoma
A recent study found that young patients with the aggressive brain cancer medulloblastoma have a unique molecular makeup in their cerebrospinal fluid, which might be useful for diagnosis and monitoring the presence of a tumor in the central nervous system. More...08 Mar 2022
Single-Antigen Assays Increase Clinical Laboratory's Ability to Identify Acceptable Donors for Transplants
A portfolio of newly-launched single antigen assays increases the ability of clinical laboratories to find acceptable donors in order to provide new beginnings for more transplant patients. More...08 Mar 2022
Gold Member
Hematology Analyzer
Medonic M32B
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
8-Channel Pipette
SAPPHIRE 20–300 µL
In Other News
Semiconductor Microchip Detects Prostate Cancer Markers With Ultra-High Sensitivity
Biomérieux Launches Free Mobile App to Aid Clinicians in Emergency and Critical Care Diagnostics
Mitochondrial Damage May Explain the Increased Incidence of Hypertension in Black Adults
TTMV-HPV DNA Biomarker Predicts Recurrence of Oropharynx Cancer
Two Important Cardiovascular Disease Risk Factors Operate Independently
Sensitive Diagnostic Test for Alzheimer’s Disease Demonstrates Accuracy Over Multiple Laboratories and Protocols
Novel Biomarkers Predict Response of Melanoma Patients to Immunotherapy
Whole-Genome Sequencing Diagnoses Neurological Repeat Expansion Disorders
High-Risk Subtype of Relapsed Pediatric Acute Myeloid Leukemia Revealed
C-reactive Protein Level Can Replace Erythrocyte Sedimentation Rate for Defining the Severity of Ulcerative Colitis
Genome Sequencing Investigated for Prenatal Diagnosis of Fetal Structural Anomalies
Genetic Signature Predicts Patients’ Response to Gastric Cancer Therapy
LumiraDx C-Reactive Protein (CRP) Test Achieves CE Marking
New Method for Three-Dimensional Analysis of Cancer Cells Shows Diagnostic Potential
Titin-Truncating Variant Associated With Late-Onset Dilated Cardiomyopathy
New Pathogen Detection Assay Pairs Molecular Inversion Probes, Next-Generation Sequencing
Metabolomics-Based Test Detects Early-Stage Lung Cancer and Predicts Patient Survival Time
Sensitive Protein Assay Differentiates Parkinson’s Disease from Other Synucleinopathies
World's First Genomic Test for Personalized HER2+ Breast Cancer Treatment Could Revolutionize Precision Oncology
dd-cfDNA Test for Assessing Kidney Transplant Rejection Performs Strongly in Real-World Study
CRISPR-based Assay Platform Detects Multiple Viruses and COVID-19 Variants
New In-Vitro Diagnostic Kits Help Patients Fight Cancer in Europe
Personalized Molecular Monitoring Assay Uses Algorithms for Early Detection of ctDNA
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
